Colinz Laboratories Limited

₹68.99As of Sun 8 Nov 2026, 12:00 UTC
BSE:531210Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 14.19%
Div yield —
ROE 5.27%
Pharmaceutical Preparations
Beta (5Y) (0.02)
PE TTM 6.212
TSR TTM 66.12%
Mkt cap ₹173.8M
ROIC 7.61%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹83
20.85%
(20.91%)
Hold 11|1|4|0|8
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.81
0.86
0.91
0.99
4.73%
6.69%
14.58%
25.85%
Revenue₹M
13.37
13.66
14.25
14.28
15.13%
13.51%
12.56%
6.70%
Peers (US$1.851M)
Cap (US$)
PE
1.808M
402.9x
1.637M
12.87x
Capital
TTM
5Y
10Y
Leveragex
1.147
0.488
0.341
EBIT/Intx
4.618
0.284
0.253
Own earn%
67.34
(24.30)
(45.34)
Sh yield%
20.43
26.99
24.23
Owners
Insiders/Inst%
5.67
87.98
Short interest%
1.29
SBC / revenue%
0.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
20–25
$1 testx
—
Incr. ROIC%
4